COVID-19

Addressing SARS-CoV-2 Variant Infections Following Vaccination

Variants in the S gene of SARS-CoV-2 have raised concerns regarding trends in viral transmissibility, virulence, and potential evasion of current vaccines.

Real World Study Shows Power of Vaccines to Prevent COVID-19

Symptomatic and asymptomatic infection reduced by 81 percent after partial vaccination and by 91 percent after full vaccination.

COVID-19 Vaccine Patent Rules Reconsidered by World Trade Organization

Idea backed by more than 60 countries, including the United States.

India to Provide Free COVID-19 Shots for All Adults

So far, just over 222 million vaccines have been given in India; less than 5 percent of its population has been fully vaccinated.

Multispecialty Perspectives on Long COVID-19

Experts in infectious disease, pulmonology, cardiology, neurology, and psychiatry share their perspectives on the phenomenon that is long COVID-19.

Pfizer-Biotech COVID-19 Vaccine Antibody Response Lower in Older Adults

Researchers compared the antibody responses of 2 age groups, one younger than 60 years and one older than 80 years, to the first and second doses of the Pfizer-BioNTech COVID-19 vaccination.

Monoclonal Antibodies for COVID-19: Expert Insights

The IDSA recommends that antibody therapy should be administered to patients with mild to moderate COVID-19 at high risk for progression to severe disease.

Can Face Touching Improve Ocular Health?

Investigators ask if developing microbiome from face touching can protect against foreign and opportunistic pathogens.

Expiration Date Looming for Millions of J&J COVID-19 Vaccine Doses

Research into extending the shelf life of the one-dose vaccine is ongoing

COVID-19 Vaccines

Types of COVID-19 vaccines in the US, including those approved by the FDA under Emergency Use Authorization, as well as other investigational products currently in Phase 3 clinical trials.